LuminaScanX operates a hub-and-spoke network coordinated by a single technology spine. Flagship hubs carry the full modality range including MRI, CT and (from Phase II) nuclear medicine; spokes and mobile units carry X-ray, ultrasound and, where volumes justify, CT, with all reporting routed to a centralised subspecialist hub. This architecture concentrates the most expensive assets and the scarcest skills where they are most productive, while extending access widely.

LuminaScan Digital™ — the technology spine

A cloud-native Radiology Information System (RIS) and Picture Archiving and Communication System (PACS) form the operational core. Patients book online, receive images and reports through a mobile app, and are billed electronically; referrers submit electronic referrals and access images and reports through a secure portal. Studies flow into a single worklist from which the reporting hub allocates them to the right subspecialist, on-site or remote, and AI pre-processing flags urgent findings and triages routine work.

Teleradiology and AI

Teleradiology decouples where a scan is acquired from where it is read, allowing the Company to serve rural hospitals, clinics and third-party providers, and, over time, other African markets, from its reporting hub. AI models assist with lung-nodule, stroke, fracture, breast and cardiac detection, reducing turnaround, prioritising critical cases and extending the reach of every radiologist hour. Together they are the operational expression of the scarcity thesis in Section 3.

Capacity, throughput and quality

Each modality is planned to a target utilisation that balances access against asset productivity. Throughput rises as centres mature and as AI removes low-value steps; average revenue per study also rises as the mix shifts toward MRI, CT and nuclear medicine. Quality is governed by HPCSA scope-of-practice standards, radiation-safety protocols (including low-dose CT), peer review and structured reporting.

The medical-scheme claims cycle

Operationally, the defining working-capital feature is the scheme settlement cycle. Studies are delivered on referral, claimed against schemes, and settled within 30–60 days. As volumes scale, receivables build to roughly 18% of revenue; a dedicated revolving facility (Section 14) bridges the gap so that growth is never constrained by the timing of scheme payments.